A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies
Infectious diseases caused by pathogenic bacteria are a major threat to human health. Capsular polysaccharides (CPSs) of many pathogenic bacteria have been used as the main components of glycoconjugate vaccines against bacterial diseases in clinical practice worldwide, with various degrees of succe...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb58032aba484ba29def28d000156c12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bb58032aba484ba29def28d000156c12 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bb58032aba484ba29def28d000156c122021-11-03T21:15:03ZA Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies2150-751110.1128/mBio.00800-21https://doaj.org/article/bb58032aba484ba29def28d000156c122021-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00800-21https://doaj.org/toc/2150-7511 Infectious diseases caused by pathogenic bacteria are a major threat to human health. Capsular polysaccharides (CPSs) of many pathogenic bacteria have been used as the main components of glycoconjugate vaccines against bacterial diseases in clinical practice worldwide, with various degrees of success.Ahmet OzdilekJiachen HuangRachelle BabbAmy V. PaschallDustin R. MiddletonJeremy A. DukeLiise-anne PirofskiJarrod J. MousaFikri Y. AvciAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 3 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 Ahmet Ozdilek Jiachen Huang Rachelle Babb Amy V. Paschall Dustin R. Middleton Jeremy A. Duke Liise-anne Pirofski Jarrod J. Mousa Fikri Y. Avci A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies |
description |
Infectious diseases caused by pathogenic bacteria are a major threat to human health. Capsular polysaccharides (CPSs) of many pathogenic bacteria have been used as the main components of glycoconjugate vaccines against bacterial diseases in clinical practice worldwide, with various degrees of success. |
format |
article |
author |
Ahmet Ozdilek Jiachen Huang Rachelle Babb Amy V. Paschall Dustin R. Middleton Jeremy A. Duke Liise-anne Pirofski Jarrod J. Mousa Fikri Y. Avci |
author_facet |
Ahmet Ozdilek Jiachen Huang Rachelle Babb Amy V. Paschall Dustin R. Middleton Jeremy A. Duke Liise-anne Pirofski Jarrod J. Mousa Fikri Y. Avci |
author_sort |
Ahmet Ozdilek |
title |
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies |
title_short |
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies |
title_full |
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies |
title_fullStr |
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies |
title_full_unstemmed |
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies |
title_sort |
structural model for the ligand binding of pneumococcal serotype 3 capsular polysaccharide-specific protective antibodies |
publisher |
American Society for Microbiology |
publishDate |
2021 |
url |
https://doaj.org/article/bb58032aba484ba29def28d000156c12 |
work_keys_str_mv |
AT ahmetozdilek astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT jiachenhuang astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT rachellebabb astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT amyvpaschall astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT dustinrmiddleton astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT jeremyaduke astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT liiseannepirofski astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT jarrodjmousa astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT fikriyavci astructuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT ahmetozdilek structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT jiachenhuang structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT rachellebabb structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT amyvpaschall structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT dustinrmiddleton structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT jeremyaduke structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT liiseannepirofski structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT jarrodjmousa structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies AT fikriyavci structuralmodelfortheligandbindingofpneumococcalserotype3capsularpolysaccharidespecificprotectiveantibodies |
_version_ |
1718445418080108544 |